For partners
For VCs and PE operating partners, biotech law firms, CROs and regulatory firms, banks and trade agencies whose clients need senior commercial leadership.
When to introduce a company
A portfolio company is approaching launch without a commercial leader; a launch is behind plan; you need commercial diligence or a launch-case stress test before investing. Not advice from the sidelines: an operator who has run P&Ls up to $2.2B.
A client is negotiating a licensing or co-promotion deal and needs the commercial case behind the terms; a client is choosing between partnering and building in the U.S.
A sponsor is nearing approval and has a clinical and regulatory plan but no commercial one.
A client needs an independent read on a commercial forecast, or a commercial leader around a transaction.
A company from your country is preparing to enter the U.S. market with a medicine or a healthcare product.
How I work alongside you
What your client gets
30 days
The entry point: an independent read of your launch plan, forecast, access strategy and budget, with the risks that matter most, in order, in writing.
See what’s included6 weeks
A board-ready U.S. launch plan, built with your team in six weeks.
See what’s included1–2 days a week
Senior commercial leadership inside your company, part time, to launch, turn around or accelerate a brand. Equity option available.
See what’s includedCareer results from roles at Novartis, not Scalar Group client results: see the track record.
30-minute call with Emilio
A 30-minute call is enough to tell whether it’s a fit. Introductions can also come by email.
I reply personally.